nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Application of DOE to ELISA Robustness and Ruggedness Assessment
|
Follmer, Thy |
|
|
27 |
3 |
|
artikel |
2 |
A Tool to Eliminate IgM Immunoassay Interference
|
Pöhler, Alexander |
|
|
27 |
3 |
|
artikel |
3 |
Effect of FcRn Binding on Monoclonal Antibody Disposition in the Brain
|
Huang, Hsien Wei |
|
|
27 |
3 |
|
artikel |
4 |
Establishing a Platform Method for Physical Appearance Assessment of New Parenteral Pharmaceuticals
|
Wan, Ying |
|
|
27 |
3 |
|
artikel |
5 |
GCN-BBB: Deep Learning Blood-Brain Barrier (BBB) Permeability PharmacoAnalytics with Graph Convolutional Neural (GCN) Network
|
Jing, Yankang |
|
|
27 |
3 |
|
artikel |
6 |
Leveraging Buprenorphine and Halofantrine as Tool Molecules to Develop a Novel Semi-Physiologically based Pharmacokinetic Model Accounting for Gastro-Intestinal Lymphatic Absorption and Enabling Cross-Species Translation
|
Tao, Xun |
|
|
27 |
3 |
|
artikel |
7 |
Lipid Nanoparticles for mRNA Delivery in Cancer Immunotherapy
|
Alshehry, Yasir |
|
|
27 |
3 |
|
artikel |
8 |
Nomlabofusp, a Fusion Protein of Human Frataxin and a Cell Penetrant Peptide, Delivers Mature and Functional Frataxin into Mitochondria
|
Baile, Matthew G. |
|
|
27 |
3 |
|
artikel |
9 |
Survey and Establishment of Points to Consider for Application of Analytical Techniques to Evaluate Protein Aggregates and Insoluble Particles in Biopharmaceuticals: Experiences in Japan Biopharmaceutical Consortium
|
Shibata, Hiroko |
|
|
27 |
3 |
|
artikel |
10 |
The Drug Titration Paradox in the Presence of Intra-Individual Variation: Can we Estimate the True Concentration-Effect Relationship?
|
Goulooze, Sebastiaan C. |
|
|
27 |
3 |
|
artikel |
11 |
Virtual Bioequivalence Assessment of Tofacitinib Once Daily Modified Release Dosage Form in Pediatric Subjects
|
Sagawa, Kazuko |
|
|
27 |
3 |
|
artikel |